Publications by authors named "F Fusetti"

Claim this Profile
P
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 2: "The How").
Nico van de Merbel, Mark Jean Gnoth, Amanda Wilson, Peter Blattmann, Benno Ingelse, Fabrizia Fusetti

Bioanalysis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspective on LC-MS(/MS) for biotherapeutic and biomarker proteins in research and regulated Bioanalysis: a consolidation of more than a decade of experience across the European Bioanalysis Forum community (Part 1: "The What").
Amanda Wilson, Mark Jean Gnoth, Nico van de Merbel, Peter Blattmann, Benno Ingelse, Fabrizia Fusetti

Bioanalysis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunocapture LC-MS(/MS) assays for biotherapeutic and biomarker proteins: the European Bioanalysis Forum continuing discussions on scientific and regulatory challenges.
Matthew Barfield, Michael Blackburn, Peter Blattmann, Benno Ingelse, Gregor Jordan, Fabrizia Fusetti

Bioanalysis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab.
Sandor Schokker, Fabrizia Fusetti, Francesco Bonardi, Remco J Molenaar, Ron A A Mathôt

MAbs· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition.
H Rudolf de Boer, Martin Pool, Esméé Joosten, Marieke Everts, Douwe F Samplonius, Fabrizia Fusetti

Oncogene· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis